Back to Rankings

OXBR

Oxbridge ReB
Nasdaq / Insurance
Last Price
At close
2026-06-02
View Chart

AI scenario view

RankAlpha Sentiment Codex
B+
Bull case
25%
Probability
Target price
$1.10
+11.8% vs current
Most likely
B
Base case
45%
Probability
Target price
$0.65
-33.9% vs current
B-
Bear case
30%
Probability
Target price
$0.30
-69.5% vs current

AI sentiment snapshot

Latest data as of 2026-04-15
Recent news sentiment (30D)
+18.4
Positive
Company
+23.6
Positive
Macro
+18.6
Positive
Pulse
-32.0
Negative
Sentiment proxy
+15.0
Score

AI commentary

Sentiment is cautious to mixed as of April 15, 2026. Management has supplied a credible primary-source narrative around tokenized-product performance, network expansion, and year-end liquidity, but the harder evidence still shows a loss-making insurer with storm exposure and limited proof that outside investor demand is scaling fast enough to change the earnings profile [#8-K-2026-03-30] [#10-K-2026-03-30] [#PR-2026-02-10] [#PR-2026-03-30]. The deterministic prior is now neutral/slightly negative, so this remains a monitoring-style setup rather than a strong bullish thesis.

RankAlpha Sentiment Codex - 2026-04-15
Open full AI memo

Evidence flagged

No evidence quality warning is currently attached to this memo.

Impact
standard
Confidence
-

AI events

2026-05-15eventQ1 2026 update on underwriting normalization and liquidityHigh impact

FY2025 showed a $2.08 million net loss, a 264.1% combined ratio, and Hurricane Milton-driven adverse development, but Q4 turned modestly profitable and year-end cash plus restricted cash reached about $6.98 million; a Q1 2026 update that shows cleaner catastrophe runoff and stable collateral could improve confidence, while another weak quarter would reinforce the monitoring stance [#8-K-2026-03-30] [#10-K-2026-03-30] [#PR-2026-03-30].

2026-05-31catalystPost-subscription disclosure for 2026-27 T20/T42 offeringHigh impact

SurancePlus launched the 2026-27 T20-2027 and T42-2027 tokenized reinsurance offering on February 10, 2026, with subscriptions accepted through March 31, 2026; the next useful proof point is whether management discloses actual take-up, third-party participation, and any capital formed beyond headline targets, because current evidence mostly shows launch and targeted returns rather than closed demand [#PR-2026-02-10].

2026-12-31catalystCommercial proof that tokenized reinsurance can scale beyond pilot statusHigh impact

Management says SurancePlus now spans Solana distribution, LayerZero interoperability across 160+ networks, and is evaluating expansion into additional cash-generating assets, but the investable question is still commercialization rather than technology; durable re-rating likely requires repeated third-party issuance, fee economics, and evidence that the token platform can matter relative to the legacy reinsurance base [#10-K-2026-03-30] [#PR-2026-03-30].

View full catalyst timeline

Recommendation

N/A

No formal recommendation provided.

Open AI Memo
As of 2026-04-15 • Updated nightlySource: Internal modelMethodology